Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment particularly challenging. While surgery remains the standard option, it often leads to scarring and other complications. Current in vitro models struggle to capture the complexity of the skin tumor environment, especially the role of immune cells. These limitations …
RNA sequencing unlocks new insights into DFSP treatment with patient-derived organoids
Share.
